The team of Professor Dr Stefan R. Bornstein, Director of the Department of Medicine III in Dresden, implanted the bio-reactor in a patient. The results of the first year are now published in the Journal of Proceedings of the National Academy of Sciences (PNAS 2013; doi:10.1073/pnas.1317561110).
The novel approach has the potential to replace the transplantation with subsequent immunosuppression. However, more research and a broader study is necessary before a large number of type 1 diabetes patients could benefit from this findings.
For the very first time ever, a patient with type 1 diabetes got an artificial pancreas system implanted which produces vital insulin in islet cells like in the pancreas. The small bio-reactor which looks like a little tin has been in the patient body for about one year. The artificial system which has been developed by an Israeli company supersedes an immunosuppression completely. The donor cells will be protected against immune system responses of the patient.
In reverse the insulin will be released into the body. Prof Bornstein, Director of the Department of Medicine III at the University Hospital: “The controlled supply of the cells with oxygen is vital to keep them alive.” He is convinced that the new system shall revolutionise the therapy of diabetes. Many more patients with diabetes type 1 will benefit from a transplantation of islet cells because the recipients do not need any immunosuppressive drugs for their lifetime.
„This is further proof of 20 years successful alliance of medical research and care in Dresden”, says Prof. Michael Albrecht, Medical Manager of the University Hospital Carl Gustav Carus. “This impressive result shows our demand implementing basic research in favour of our patients – the primary objective of the Medical Faculty in Dresden”, says Prof Dr Heinz Reichmann, dean of Medical Faculty Carl Gustav Carus of Technical University Dresden.
Nobel medicine winner Prof Andrew V. Schally of Miller School of Medicine at the University of Miami, who has a research collaboration with Dresden, pronounced “This is a success of historical meaning“. Despite medication, some patients with type 1 diabetes suffer of life threatening deviation of their glucose balance. Transplantation of pancreas as well as islet cells are the only two options to replace insulin producing beta cells and restore the physiological function of insulin production. Both options mean a considerably better control of diabetes and quality of life for the patient. However, the permanent taking of immunosuppressive drugs makes patients susceptible for infections and other adverse effects like a higher risk of cancer. Therefore, these treatments were considered for patients with special medical requirements only.
Dr Barbara Ludwig started the program of transplantation of human beta cells of the islets of Langerhans in 2008. It is the first and only centre of its kind in Germany. The main interest of Dr Ludwig’s group is the quality improvement of human beta cell transplantations. The artificial pancreas system was intensively tested in animals with the colleagues from Israel. The result of this cooperation project was recently published in Proceedings of the National Academy of Sciences (PNAS 2013; doi:10.1073/pnas.1317561110).
Surely, more work has to be done, but Prof Bornstein is certain that the new system will be a serious option in therapy of diabetes in five years time.Contact:
Susanne Witzigmann | idw
Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania
The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction